| Patents for C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033) |
|---|
| 05/21/2002 | US6392036 Sanitizing particles in sample; obtain sample, expose to heat, monitor sample for antiseptic nature |
| 05/16/2002 | US20020058651 Estra-1,3,5(10), 16-tetraene derivatives |
| 05/10/2002 | WO2002036606A1 Selective glucocorticoid receptor agonists |
| 05/10/2002 | WO2002036106A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 05/08/2002 | CN1348373A Use of 17-ketosteroids for the treatment of malaria and Trypanosomiasis |
| 05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 04/11/2002 | WO2001032680A3 18-nor-steroids as selectively active estrogens |
| 04/03/2002 | EP0988312B1 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 03/28/2002 | WO2002000679A3 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/27/2002 | EP1189922A1 Steroid derivatives |
| 03/05/2002 | US6352980 Estrenes for inducting hypothalamic effects |
| 02/21/2002 | WO2002014343A1 Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents |
| 02/21/2002 | WO2001081328A3 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 02/14/2002 | US20020019378 Compounds |
| 01/31/2002 | WO2002008243A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 01/31/2002 | CA2406963A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 01/23/2002 | EP0902789B1 Androstene derivatives |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/02/2002 | CN1329103A Method for extracting protein, short peptide, nucleic acid, isoflavone, saponin and oligosaccharide by using high and low temperature soybean cake |
| 12/26/2001 | CN1328463A Use of 17-ketosteroid compounds, as well as derivatives, metabolites and precursors for treatment of hapatitis C type virus and other togavirus infections |
| 12/19/2001 | EP1163259A1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| 12/19/2001 | EP1163256A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 12/18/2001 | US6331534 Steroids as neurochemical stimulators of the VNO to alleviate pain |
| 11/01/2001 | WO2001081328A2 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 11/01/2001 | CA2402123A1 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 10/10/2001 | CN1072678C Trifluoro-methyl steroid, preparation and its application |
| 10/02/2001 | US6297228 Use of angiostatic steroids in photodynamic therapy |
| 09/26/2001 | EP1135138A2 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 09/19/2001 | EP1133287A2 Use of 17-ketosteroids for the treatment of hepatitis c virus and other togaviruses |
| 09/13/2001 | WO2001066562A1 Steroid derivatives and process for producing the same |
| 09/05/2001 | CN1070499C Process for prepn. of 6 alpha, 9 alpha-difluorinated steroids and intermediates thereof |
| 08/28/2001 | US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions |
| 08/01/2001 | CN1306005A Process for preparing medicine |
| 07/17/2001 | US6262282 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 07/17/2001 | US6262043 Show inhibitory activity against steroid sulfatase and are useful in treating or preventing hormone dependent diseases. |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 06/07/2001 | WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 06/07/2001 | CA2391096A1 3-methylene steroid derivatives |
| 05/10/2001 | WO2001032680A2 18-nor-steroids as selectively active estrogens |
| 04/19/2001 | WO2001027133A1 Process to prepare androst-4-en-17-carboxylic acid |
| 04/19/2001 | CA2383957A1 Process to prepare androst-4-en-17-carboxylic acid |
| 04/11/2001 | CN1064368C Fluoric steroid 5 alpha reductase inhibitor and synthesis process and use |
| 03/22/2001 | WO2000032177A3 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections |
| 03/08/2001 | WO2001016601A1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/08/2001 | CA2383047A1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/06/2001 | US6197761 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives |
| 02/28/2001 | CN1285750A New composition of matter |
| 02/27/2001 | CA2081205C Steroids which inhibit angiogenesis |
| 02/14/2001 | CN1061983C 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 12/21/2000 | WO2000032201A3 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 12/07/2000 | WO2000032176A3 Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis |
| 11/22/2000 | CN1058724C Use of steroid compound for preparing medicaments |
| 11/09/2000 | WO2000066611A1 Steroid derivatives |
| 11/09/2000 | CA2372493A1 Steroid derivatives |
| 10/31/2000 | US6140316 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions |
| 10/25/2000 | CN1057771C Androstenone derivative |
| 10/25/2000 | CN1057767C Androstanes with inducing hypothalamic effects |
| 10/18/2000 | CN1057531C Androstanes steroids and their medicinal compositions and uses thereof |
| 10/04/2000 | EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 09/28/2000 | WO2000056757A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 09/28/2000 | CA2365081A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 09/14/2000 | WO2000053619A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| 09/14/2000 | CA2359218A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| 09/12/2000 | US6117860 Nasally administering steroid which binds to a specific neuroepithelial receptor for alleviating premenstrual tension and anxiety |
| 09/06/2000 | EP1032396A1 New composition of matter |
| 08/30/2000 | CN1055930C Steroalkenol polyfluohydrocarbyl sulfonate compound and its deriv., use and preparing process |
| 08/30/2000 | CN1055929C Trifluoromethyl steroids compounds and prepn. thereof |
| 07/05/2000 | EP0876392B1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 07/05/2000 | CN1259138A 17 'beta'-allyloxy (thio) alkyl-androstane derivatives for the modulation of meiosis |
| 06/08/2000 | WO2000032201A2 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 06/08/2000 | WO2000032177A2 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections |
| 06/08/2000 | WO2000032176A2 Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis |
| 06/08/2000 | CA2356539A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of african and american trypanosomiasis |
| 06/08/2000 | CA2352387A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in treatment of toxoplasmosis and in the treatment of cryptosporidiosis |
| 06/08/2000 | CA2352205A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis c virus and other togaviruses |
| 05/31/2000 | EP1003553A1 The use of angiostatic steroids in photodynamic therapy |
| 05/31/2000 | EP0721459B1 Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry |
| 05/10/2000 | EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life |
| 05/10/2000 | CN1052155C Process for preparing pharmaceutical composition containing new steriod compounds |
| 05/02/2000 | US6057439 Epoxysteroids |
| 04/25/2000 | CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids |
| 04/04/2000 | US6046185 6,7-oxygenated steroids and uses related thereto |
| 03/29/2000 | EP0988312A1 17$g(b)-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS |
| 03/15/2000 | EP0533703B1 Use of steroids for the inhibition of angiogenesis |
| 03/08/2000 | EP0783513A4 Novel estrenes for inducing hypothalamic effects |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 11/30/1999 | US5994568 Estrenes for inducing hypothalamic effects |
| 11/23/1999 | US5990099 Treating glc1a glaucoma by administering an angiostatic steroid of given formula |
| 11/17/1999 | CN1235548A Method for lowering plasma levels of lipoprotein (A) |
| 11/09/1999 | US5981517 Androstene derivatives |
| 11/02/1999 | US5977126 Antiangrogens, enzyme inhbitors |
| 10/26/1999 | US5972922 Steroids which inhibit angiogenesis |
| 10/19/1999 | US5969168 Stimulate autonomic activity |
| 10/12/1999 | US5965552 Administering androsta-4,16-dien-3-ol for treating tension, reducing anxiety; administering to the vomeronasal organ of individual |
| 09/15/1999 | EP0941096A2 A method for lowering plasma levels of lipoprotein(a) |
| 08/31/1999 | US5945530 17,20-epoxy steroid intermediates |
| 08/25/1999 | CN1226837A Steroids as neurochemical stimulators of VNO to alleviate symptoms of PMS and anxiety |